Search Contract Opportunities

Acquisition of Nilotinib (Tasigna®) Capsules, or Equivalent

ID: 75N91023Q00019 • Type: Solicitation • Match:  95%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: Jan. 3, 2023, 9:17 a.m. EST

The purpose of this amendment is to extend the submission deadline until January 6, 2023, 03:00 pm EST.

This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR subpart 13.5 - Simplified Acquisition Procedures for Certain Commercial Items. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation, 75N91023Q00019, is issued as a request for quote (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2022-08 (10-28-2022), simplified acquisition procedures for commercial items.

The North American Industry Classification System code is 325412 and the business size standard is 1,250 employees. The Product or Service Code is category 6505 - Drugs and Biologicals.

The anticipated award shall be a firm fixed price, indefinite delivery/indefinite quantity (IDIQ) type contract. The Government anticipates a single-award IDIQ. The period of performance of the resulting IDIQ award shall consist of a 4-year ordering period. Multiple delivery orders are anticipated during the 4-year ordering period.

THIS IS A TOTAL SMALL BUSINESS SET-ASIDE.

REFERENCE RFQ NO. 75N91023Q00019 (ATTACHED)

Posted: Dec. 21, 2022, 1:41 p.m. EST
Background
This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR subpart 13.5 - Simplified Acquisition Procedures for Certain Commercial Items. The North American Industry Classification System code is 325412 and the business size standard is 1,250 employees. The Product or Service Code is category 6505 - Drugs and Biologicals. The anticipated award shall be a firm fixed price, indefinite delivery/indefinite quantity (IDIQ) type contract. The Government anticipates a single-award IDIQ.

Work Details
Acquisition of Nilotinib (Tasigna®) Capsules, or Equivalent

Period of Performance
The period of performance of the resulting IDIQ award shall consist of a 4-year ordering period.

Place of Performance
The geographic location(s) for delivery orders will be determined by the specific programmatic needs of the requesting agency.

Overview

Agency
National Institutes of Health (NIH) [HHS]
Response Deadline
Jan. 6, 2023, 3:00 p.m. EST (original: Jan. 4, 2023, 3:00 p.m. EST) Past Due
Posted
Dec. 21, 2022, 1:41 p.m. EST (updated: Jan. 3, 2023, 9:17 a.m. EST)
Set Aside
Small Business (SBA)
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Fixed Price
Est. Level of Competition
Average
Vehicle Type
Indefinite Delivery Contract
Signs of Shaping
97% of obligations for similar contracts within the National Institutes of Health were awarded full & open.
On 12/21/22 National Institutes of Health issued Solicitation 75N91023Q00019 for Acquisition of Nilotinib (Tasigna®) Capsules, or Equivalent due 1/6/23. The opportunity was issued with a Small Business (SBA) set aside with NAICS 325412 (SBA Size Standard 1300 Employees) and PSC 6505.
Primary Contact
Name
Dana Summons, Contract Specialist   Profile
Email
dana.summons@nih.gov
Phone
(240) 276-5319

Documents

Posted documents for Solicitation 75N91023Q00019

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 75N91023Q00019

Contract Awards

Prime contracts awarded through Solicitation 75N91023Q00019

Incumbent or Similar Awards

Contracts Similar to Solicitation 75N91023Q00019

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75N91023Q00019

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75N91023Q00019

Experts for Acquisition of Nilotinib (Tasigna®) Capsules, or Equivalent

Recommended experts avaliable for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NIH NCI
FPDS Organization Code
7529-00316
Source Organization Code
100188082
Last Updated
Jan. 21, 2023
Last Updated By
dana.summons@nih.gov
Archive Date
Jan. 21, 2023